News and blogs
175 results found.
Our position on Evusheld
Since Evusheld was approved for use by MHRA, we’ve heard from the blood cancer community that one of their greatest concerns is the delay in its rollout across the UK. We wanted to address this directly and explain the work we’ve been doing.
We're funding 13 new research projects
Find out more about the latest blood cancer research projects that will receive £3 million pounds of funding from Blood Cancer UK
Find out more about the Covid antibody treatment Evusheld
The treatment consists of two long-acting antibodies called tixagevumab and cilgavimab.
Latest updates from the Covid-19 Vaccine Research Collaborative
Find out the latest information on the Covid-19 Vaccine Research Collaborative from Blood Cancer UK.
How did the third Covid vaccine dose roll-out go so badly wrong?
We take an in-depth look at a timeline of delays, missed opportunities, and mistakes which have caused huge anxiety among people with blood cancer – and may have even led to avoidable deaths.
Re-purposing drugs could revolutionise blood cancer treatment
Discover how re-purposing drugs could help bring new treatments to people with blood cancer.
Survival rates for children and young people with leukaemia and lymphoma sees big increase
Learn more about the increase of children and young people with lymphoma and leukaemia who are surviving and beating blood cancer.
Childhood blood cancer survival rates see big improvement
Read Blood Cancer UK's analysis on the improvements in childhood blood cancer survival rates.
Supporting people with blood cancer to make decisions around clinical trials
Find out how Millie, an Advanced Nurse Practitioner, helps people with blood cancer take decisions on blood cancer clinical trials.
Blood Cancer UK research strategy - your questions answered
Read more about Blood Cancer UK's research strategy, find out how we will allocate funding, and how soon research should deliver impact for patients.
The blood cancer jigsaw: how we start to piece together the bigger picture
Read more about Blood Cancer UK's article on the similarities between blood cancer treatments, and how some drugs and research are having an impact across multiple conditions.
VIVO Biobank is formed in collaboration with Cancer Research UK
VIVO Biobank is the first national biomedical research resource dedicated to storing the samples and associated data of the full spectrum of cancers in children and young people.
Our research investment into acute myeloid leukaemia (AML)
Professor Brian Huntly discusses Blood Cancer UK's investment into research into acute myeloid leukaemia (AML)
How we helped Covid booster vaccine research
Discover how Blood Cancer UK played a key part in Covid booster vaccine research for immune compromised patients, helping to create the OCTAVE-DUO study.
Can a blood test detect cancer?
Learn more about a new blood test that looks at cell-free DNA (cfDNA) that could detect cancers earlier.
Five reasons for people with blood cancer to be hopeful about the Covid pandemic
Find out why better treatments and vaccine efficacy should make people with blood cancer more hopeful about the Covid pandemic.
Vaccine Collaborative announce further funding for vaccine efficacy research
Find out more about the increased funding into Covid vaccine efficacy research by the Blood Cancer Vaccine Research Collaborative.
We believe we can beat blood cancer within a generation - Fatima Sulaiman.
Fatima Sulaiman, Head of Research, talks about the future of blood cancer research for us as an organisation, and what we’re doing to prioritise research.
Funding for 9 blood cancer research projects announced
Find out about how Blood Cancer UK is funding 9 research projects to help people with blood cancer, including children with Schwachman-Diamond syndrome and lymphoma.
What do covid antibody test results mean for people with blood cancer?
What do covid antibody test results mean for people with blood cancer?
